Table 1 Top PGC3 SCZ-GWAS eGenes, prioritized by EpiXcan and epigenetic annotation, as epigenetic/regulatory (NEK4, UBE2Q2L, ZNF804A) and signaling (PLC1, NAGA, FES, CALN1, SNAP91) for pathway studies

From: Functional implications of polygenic risk for schizophrenia in human neurons

  

EpiXcan

ExN-PrediXcan

Epigenetic annotation

Group

Chr

Gene

z

r2

z

effect_size

P

ATACseq

H3K27ac

H3K4me3

H3K27ac (neuron)

regulatory

3

NEK4

8.64

0.26

NA

NA

NA

NA

Promoter

NA

Promoter

signaling

2

PLCL1

7.2

0.04

5.214354

0.4030863

1.84E-07

NA

Intron

Promoter

Intron

regulatory

15

UBE2Q2L

6.89

0.02

NA

NA

NA

NA

Promoter

Promoter

Promoter

signaling

22

NAGA

6.67

0.25

6.983019

0.1485328

2.89E-12

NA

Promoter

Promoter

NA

signaling

15

FES

6.63

0.05

3.917081

0.2899073

8.96E-05

NA

Promoter

Promoter

NA

signaling

7

CALN1

6.57

0.07

5.356091

0.1714315

8.50E-08

NA

Intron

Promoter

Intron

regulatory

2

ZNF804A

6.27

0.05

2.867957

5.1198005

4.13E-03

NA

Promoter

Intron

NA

  1. EpiXcan test: elastic net regression-based predictor model of methylation applied to genotype data to identify genetically regulated gene methylation, two-tailed, within tissue, Bonferroni multiple comparison correction. NEK4, PLCL1, UBE2Q2L, NAGA, FES, CALN1, and ZNF804A are present in the pooled screen SCZ1.